BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 27215596)

  • 1. Clonal Hematopoiesis of Indeterminate Potential.
    Heuser M; Thol F; Ganser A
    Dtsch Arztebl Int; 2016 May; 113(18):317-22. PubMed ID: 27215596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
    Malcovati L; Cazzola M
    Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
    Osman A; Patel JL
    Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology.
    Bou Zerdan M; Nasr L; Saba L; Meouchy P; Safi N; Allam S; Bhandari J; Chaulagain CP
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
    Karner K; George TI; Patel JL
    Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clonal haematopoiesis: A concise review].
    Danlos FX; Papo M; Micol JB
    Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?].
    Haferlach C; Heuser M
    Inn Med (Heidelb); 2022 Nov; 63(11):1141-1147. PubMed ID: 36121473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premalignant Clonal Hematopoietic Proliferations.
    Nardi V; Kuo FC; Hasserjian RP
    Am J Clin Pathol; 2019 Aug; 152(3):347-358. PubMed ID: 31305863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
    Tang G; Medeiros LJ; Wang SA
    Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.
    Ganguly BB; Banerjee D; Agarwal MB
    Blood Cells Mol Dis; 2018 Mar; 69():90-100. PubMed ID: 29079134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
    Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
    Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological Malignancies in Adults With a Family Predisposition.
    Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
    Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICUS/CCUS/CHIP: basics & beyond.
    Jain M; Tripathi A
    Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice.
    DeZern AE; Malcovati L; Ebert BL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():400-410. PubMed ID: 31099654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New challenges in evaluating anemia in older persons in the era of molecular testing.
    Steensma DP
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):67-73. PubMed ID: 27913464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.